全文获取类型
收费全文 | 326761篇 |
免费 | 23485篇 |
国内免费 | 1239篇 |
专业分类
耳鼻咽喉 | 3560篇 |
儿科学 | 9010篇 |
妇产科学 | 6356篇 |
基础医学 | 42793篇 |
口腔科学 | 6724篇 |
临床医学 | 31660篇 |
内科学 | 69136篇 |
皮肤病学 | 4216篇 |
神经病学 | 31692篇 |
特种医学 | 10593篇 |
外国民族医学 | 15篇 |
外科学 | 49503篇 |
综合类 | 4962篇 |
现状与发展 | 3篇 |
一般理论 | 441篇 |
预防医学 | 29327篇 |
眼科学 | 7553篇 |
药学 | 22817篇 |
2篇 | |
中国医学 | 639篇 |
肿瘤学 | 20483篇 |
出版年
2023年 | 1291篇 |
2022年 | 2008篇 |
2021年 | 5730篇 |
2020年 | 3494篇 |
2019年 | 5718篇 |
2018年 | 6685篇 |
2017年 | 5179篇 |
2016年 | 5748篇 |
2015年 | 6699篇 |
2014年 | 9898篇 |
2013年 | 14219篇 |
2012年 | 21126篇 |
2011年 | 22906篇 |
2010年 | 12791篇 |
2009年 | 11734篇 |
2008年 | 21240篇 |
2007年 | 22470篇 |
2006年 | 21569篇 |
2005年 | 22000篇 |
2004年 | 21015篇 |
2003年 | 19519篇 |
2002年 | 18842篇 |
2001年 | 3077篇 |
2000年 | 2363篇 |
1999年 | 3258篇 |
1998年 | 4203篇 |
1997年 | 3592篇 |
1996年 | 3082篇 |
1995年 | 2846篇 |
1994年 | 2518篇 |
1993年 | 2409篇 |
1992年 | 1874篇 |
1991年 | 1745篇 |
1990年 | 1595篇 |
1989年 | 1464篇 |
1988年 | 1508篇 |
1987年 | 1495篇 |
1986年 | 1400篇 |
1985年 | 1578篇 |
1984年 | 2027篇 |
1983年 | 1952篇 |
1982年 | 2467篇 |
1981年 | 2212篇 |
1980年 | 2049篇 |
1979年 | 1183篇 |
1978年 | 1291篇 |
1977年 | 1257篇 |
1976年 | 1113篇 |
1975年 | 950篇 |
1974年 | 939篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Umar Nadia K. Badshah Maaz B. Sandrasegaran Kumar Ghabril Marwan Agarwal Saurabh Tann Mark Lacerda Marco Kwo Paul Y. 《Digestive diseases and sciences》2015,60(7):2196-2200
Digestive Diseases and Sciences - To determine whether the presence of portal vein thrombosis (PVT) where venous flow within the liver may be altered may delay the diagnosis of HCC and be... 相似文献
92.
John P. Sundberg Kathleen A. Silva Victoria E. Kennedy John J. Wilson Nicholas E. Gott Beth A. Sundberg Derry C. Roopenian 《Experimental dermatology》2019,28(9):1091-1093
2‐deoxy D‐glucose (2DG) was tested for efficacy in treating alopecia areata using the C3H/HeJ skin graft model. 2DG has proven to be efficacious in treatment of various mouse models of autoimmunity with minimal serious side effects noted. This agent has been shown to normalize abnormally activated T‐cell populations while also preventing cell surface expression of NKG2D; key factors defining alopecia areata disease progression. Daily oral ingestion of 2DG via drinking water to mice with patchy or diffuse alopecia areata for 16 weeks failed to prevent expansion of alopecia or cause regrowth of hair in treated mice. Histologically, there were no differences between treated and control groups. These results indicate that, while 2DG is effective for some autoimmune diseases, it was not efficacious for the cell‐mediated autoimmune mouse disease, alopecia areata. 相似文献
93.
Dane Scantling Robert Kucejko John Williamson Alvaro Galvez Amanda Teichman Ryan Gruner Nicholas Serniak Brendan McCracken 《Injury》2019,50(1):54-60
Background
Most elderly trauma patients suffer blunt head injury and many utilize antithrombotic (AT) medications. The utility of delayed CT-head (D-CTH) in neurologically intact elderly patients using AT who have an intracranial hemorrhage (ICH) on presentation is unknown. We hypothesized that D-CTH would not alter clinical management and aimed to evaluate the role of D-CTH in this population.Methods
A retrospective cohort study was performed. Patients ≥65 years sustaining blunt head injuries from January 2010 to July 2017 were identified using our level 1 trauma center database. AT-patients presenting with ICH who underwent D-CTH were included. Patients with worsened ICH were compared to those with stable to improved ICH on D-CTH. AT-patients were compared to a cohort of non-AT patients. Fisher’s Exact and Mann-Whitney U tests were utilized and a power analysis conducted.Results
137?A?T and 34 non-AT patients were identified. There was no difference in hemorrhage progression or appearance of new ICH. No patient had a change in management from D-CTH in either cohort. AT-patients were slightly older (p?<?0.001), but cohorts were otherwise similar.50 AT-patients with worsened ICH were compared to 87 with stable ICH. There was no difference in cohort demographics. Hemorrhage progression did not vary with type of AT used but did increase if multiple types of synchronous ICH were present (p?<?0.001).Conclusions
Our data supports abstaining from routine D-CTH of elderly ICH patients with an intact neurologic examination who are utilizing aspirin, clopidogrel or warfarin. Conclusions cannot be drawn regarding new oral anticoagulants (NOACs) given low enrollment. Further multicenter study is required to provide adequate power and detect small levels of management change. 相似文献94.
95.
96.
97.
98.
Grulois Daphné Tiavouane Josina Dumas Pascal Paul Fauvelot Cécile 《Conservation Genetics Resources》2015,7(1):73-75
Conservation Genetics Resources - Fifteen polymorphic microsatellite markers were developed for Tridacna maxima in order to assess self-recruitment and larval dispersal within and among MPAs in New... 相似文献
99.
Julie A. Schmidt Georgina K. Fensom Sabina Rinaldi Augustin Scalbert Paul N. Appleby David Achaintre Audrey Gicquiau Marc J. Gunter Pietro Ferrari Rudolf Kaaks Tilman Kühn Heiner Boeing Antonia Trichopoulou Anna Karakatsani Eleni Peppa Domenico Palli Sabina Sieri Rosario Tumino Bas Bueno-de-Mesquita Antonio Agudo Maria-Jose Sánchez María-Dolores Chirlaque Eva Ardanaz Nerea Larrañaga Aurora Perez-Cornago Nada Assi Elio Riboli Konstantinos K. Tsilidis Timothy J. Key Ruth C. Travis 《International journal of cancer. Journal international du cancer》2020,146(3):720-730
Metabolomics may reveal novel insights into the etiology of prostate cancer, for which few risk factors are established. We investigated the association between patterns in baseline plasma metabolite profile and subsequent prostate cancer risk, using data from 3,057 matched case–control sets from the European Prospective Investigation into Cancer and Nutrition (EPIC). We measured 119 metabolite concentrations in plasma samples, collected on average 9.4 years before diagnosis, by mass spectrometry (AbsoluteIDQ p180 Kit, Biocrates Life Sciences AG). Metabolite patterns were identified using treelet transform, a statistical method for identification of groups of correlated metabolites. Associations of metabolite patterns with prostate cancer risk (OR1SD) were estimated by conditional logistic regression. Supplementary analyses were conducted for metabolite patterns derived using principal component analysis and for individual metabolites. Men with metabolite profiles characterized by higher concentrations of either phosphatidylcholines or hydroxysphingomyelins (OR1SD = 0.77, 95% confidence interval 0.66–0.89), acylcarnitines C18:1 and C18:2, glutamate, ornithine and taurine (OR1SD = 0.72, 0.57–0.90), or lysophosphatidylcholines (OR1SD = 0.81, 0.69–0.95) had lower risk of advanced stage prostate cancer at diagnosis, with no evidence of heterogeneity by follow-up time. Similar associations were observed for the two former patterns with aggressive disease risk (the more aggressive subset of advanced stage), while the latter pattern was inversely related to risk of prostate cancer death (OR1SD = 0.77, 0.61–0.96). No associations were observed for prostate cancer overall or less aggressive tumor subtypes. In conclusion, metabolite patterns may be related to lower risk of more aggressive prostate tumors and prostate cancer death, and might be relevant to etiology of advanced stage prostate cancer. 相似文献
100.